The purpose of this study is to evaluate long-term effectiveness and safety of patients with coronary disease treated with drug eluting balloon in real world practice.
Study Type
OBSERVATIONAL
Enrollment
1,500
Soon Chun Hyang University Hospital Bucheon
Bucheon-si, South Korea
TERMINATEDKeimyung University Dongsan Medical Center
Daegu, South Korea
RECRUITINGThe Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, South Korea
Composite Event
Death, Non-fatal myocardial infarction, Target vessel revascularization
Time frame: 1year
All cause death
Time frame: 5year
Cardiac death
Time frame: 5year
Myocardial infarction
Time frame: 5year
Composite event
Death or myocardial infarction
Time frame: 5year
Composite event
Cardiac death or myocardial infarction
Time frame: 5year
Target vessel revascularization
Time frame: 5year
Target lesion revascularization
Time frame: 5year
Stent thrombosis
Classification of stent thrombosis according to Academic Research Consortium criteria
Time frame: 5year
Stroke
Time frame: 5year
Procedural Success
Defined as less than 30% residual stenosis at the completion of procedure without death or Q wave myocardial infarction or urgent revascularization. Participants will be followed for the duration of hospital stay, an expected average of 3days.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Chonnam National University Hospital
Gwangju, South Korea
RECRUITINGDong-A Medical Center
Pusan, South Korea
RECRUITINGAsan Medical Center
Seoul, South Korea
RECRUITINGGangnam Severance Hospital
Seoul, South Korea
RECRUITINGKorea University Guro Hospital
Seoul, South Korea
NOT_YET_RECRUITINGUlsan University Hospital
Ulsan, South Korea
RECRUITINGTime frame: 3day